3rd Quarter - Report

WILLKIE FARR & GALLAGHER LLP for TEVA PHARMACEUTICALS USA INC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Legislation affecting pharmaceutical patent litigation, including settlement of patent infringement claims (H.R. 1706 and S. 369).

Foreign entity interest: TEVA Pharmaceutical Industries, Ltd. shares the interest of its subsidiary, TEVA Pharmaceuticals USA, in the legislation indicated above.

LobbyistCovered position, as disclosed
THEODORE CASE WHITEHOUSE —

Bills named: H.R. 1706 (111th), S. 369 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.